FDA Announces Approval of Guidance for Continuous Marketing Applications Under PDUFA

Summary

The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) for a collection of information related to guidance on continuous marketing applications for fast track products under the Prescription Drug User Fee Act (PDUFA).